Temozolomid Devatis 5 mg
Temozolomid Devatis 5 mg is a medicine authorised by Swissmedic under authorisation number 68606. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 17 November 2022 and the authorisation is limited until 16 November 2027. ATC code L01AX03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68606 |
|---|---|
| Name | Temozolomid Devatis 5 mg |
| Full name | Temozolomid Devatis 5 mg, Kapseln |
| Authorisation holder | Devatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01AX03 |
| First authorisation | 17 November 2022 |
| Authorisation validity | 16 November 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Temozolomid Devatis 5 mg, Kapseln | A | 17 November 2022 |
| 2 | Temozolomid Devatis 20 mg, Kapseln | A | 17 November 2022 |
| 3 | Temozolomid Devatis 100 mg, Kapseln | A | 17 November 2022 |
| 4 | Temozolomid Devatis 140 mg, Kapseln | A | 17 November 2022 |
| 5 | Temozolomid Devatis 180 mg, Kapseln | A | 17 November 2022 |
| 6 | Temozolomid Devatis 250 mg, Kapseln | A | 17 November 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 2 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 3 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 4 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 5 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 6 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 7 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 8 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 9 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 10 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 11 | 5 | Kapsel(n) | L01AX03 | 07.16.1. | A |
| 12 | 20 | Kapsel(n) | L01AX03 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Temozolomid Devatis 5 mg authorised in Switzerland?
Yes. Temozolomid Devatis 5 mg is authorised by Swissmedic under authorisation number 68606, data as of 01 September 2026. The authorisation is limited until 16 November 2027.
Which dispensing category does Temozolomid Devatis 5 mg have?
Temozolomid Devatis 5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Temozolomid Devatis 5 mg?
The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.